Estrogens and Estrogen Receptor Modulators in Cancer Research and Therapy.

Autor: Treeck O; Department of Gynecology and Obstetrics I, University Medical Center Regensburg, 93053 Regensburg, Germany.

Publikováno v: Cancers [Cancers (Basel)] 2023 Aug 29; Vol. 15 (17). Date of Electronic Publication: 2023 Aug 29.

Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer.

Autor: Schüler-Toprak S; Department of Obstetrics and Gynecology, University Medical Center Regensburg, Caritas-Hospital St. Josef, 93053 Regensburg, Germany., Skrzypczak M; Second Department of Gynecology, Medical University of Lublin, 20-954 Lublin, Poland., Gründker C; Department of Gynecology and Obstetrics, University Medical Center Göttingen, 37075 Göttingen, Germany., Ortmann O; Department of Obstetrics and Gynecology, University Medical Center Regensburg, Caritas-Hospital St. Josef, 93053 Regensburg, Germany., Treeck O; Department of Obstetrics and Gynecology, University Medical Center Regensburg, Caritas-Hospital St. Josef, 93053 Regensburg, Germany.

Publikováno v: Cancers [Cancers (Basel)] 2023 May 20; Vol. 15 (10). Date of Electronic Publication: 2023 May 20.

Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling.

Autor: Weber F; Institute for Pathology, University of Regensburg, 93053 Regensburg, Germany., Schueler-Toprak S; Department of Gynecology and Obstetrics, University Medical Center Regensburg, 93053 Regensburg, Germany., Buechler C; Department of Internal Medicine I, University Medical Center Regensburg, 93053 Regensburg, Germany., Ortmann O; Department of Gynecology and Obstetrics, University Medical Center Regensburg, 93053 Regensburg, Germany., Treeck O; Department of Gynecology and Obstetrics, University Medical Center Regensburg, 93053 Regensburg, Germany.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Mar 02; Vol. 13 (5). Date of Electronic Publication: 2023 Mar 02.

G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.

Autor: Schüler-Toprak S; Department of Obstetrics and Gynecology, Laboratory for Molecular Oncology, University Medical Center Regensburg, Landshuter Street 65, 93053, Regensburg, Germany., Skrzypczak M; Second Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, 20-090, Lublin, PL, Poland., Ignatov T; Department of Obstetrics and Gynecology, Laboratory for Molecular Oncology, University Medical Center Regensburg, Landshuter Street 65, 93053, Regensburg, Germany., Ignatov A; Department of Obstetrics and Gynecology, Laboratory for Molecular Oncology, University Medical Center Regensburg, Landshuter Street 65, 93053, Regensburg, Germany., Ortmann O; Department of Obstetrics and Gynecology, Laboratory for Molecular Oncology, University Medical Center Regensburg, Landshuter Street 65, 93053, Regensburg, Germany., Treeck O; Department of Obstetrics and Gynecology, Laboratory for Molecular Oncology, University Medical Center Regensburg, Landshuter Street 65, 93053, Regensburg, Germany. otreeck@caritasstjosef.de.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Dec; Vol. 146 (12), pp. 3175-3188. Date of Electronic Publication: 2020 Aug 19.

Chemerin and Chemokine-like Receptor 1 Are Not Prognostic in Colorectal Carcinoma.

Autor: Weber F; Institute of Pathology, University of Regensburg, Regensburg, Germany., Jung R; Institute of Pathology, University of Regensburg, Regensburg, Germany., Treeck O; Department of Gynaecology and Obstetrics, Regensburg University Hospital, Regensburg, Germany., Buechler C; Department of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany christa.buechler@klinik.uni-regensburg.de.

Publikováno v: Anticancer research [Anticancer Res] 2023 Feb; Vol. 43 (2), pp. 831-839.